Cilazapril: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 33: Line 33:


[[Category:ACE inhibitors]]
[[Category:ACE inhibitors]]
[[Category:Enantiopure drugs]]
[[Category:Ethyl esters]]
[[Category:Lactams]]
[[Category:Lactams]]
[[Category:Carboxylic acids]]
[[Category:Carboxylic acids]]

Revision as of 19:29, 23 July 2014

Cilazapril
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H33N3O6
Molar mass435.514 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Sheng Shi, M.D. [2]

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1][2] It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these are available in the United States as of May 2010.[3]

Of the eight possible stereoisomers, only the all-S form is medically viable.[citation needed]

  1. ↑ PMID 1712267 (PMID 1712267)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  2. ↑ Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
  3. ↑ Drugs.com: Cilazapril


Retrieved from "https://www.wikidoc.org/index.php?title=Cilazapril&oldid=999811"